Clinical Trials Logo
  1. Home
  2. Renal Injury
  3. NCT04265599

Exploring Pathogenesis and Treatment of Hypercalcemia Caused by Intramuscular Injection of Paraffinoil

Hypercalcemia Clinical Trial

Official title:
Hypercalcemia After Cosmetic Paraffin Oil Injections: Unravelling Etiology, Pathogenesis and Potential Treatments

Clinical Trial Summary

The aim of the study is to characterize paraffin oil induced granulomatous disease. We will investigate pathogenesis and natural history of paraffin disease. Subsequently, through further translational studies, we intend to identify novel treatments to be tested in future randomized clinical trials.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04265599
Study type Observational
Source Herlev Hospital
Contact Ebbe Eldrup, DMSc
Phone +45 38681154
Email ebbe.eldrup@regionh.dk
Status Recruiting
Phase
Start date April 30, 2019
Completion date January 31, 2025
View Details
See also
  Status Clinical Trial Phase
Withdrawn NCT02711059 - Insulin Resistance in Primary Hyperparathyroidism N/A
Recruiting NCT05585593 - Registry for Hypoparathyroidism Wuerzburg
Terminated NCT01725113 - Management of Mineral and Bone Disease in Hemodialysis-Calcitriol vs. Paricalcitol Phase 4
Completed NCT01460030 - An Intra-individual Titration Study of KRN1493 for the Treatment of Hypercalcemia in Patients With Parathyroid Carcinoma or Intractable Primary Hyperparathyroidism Phase 3
Completed NCT00325104 - Cinacalcet to Treat Familial Primary Hyperparathyroidism Phase 3
Recruiting NCT03935984 - Calcitonin Pre-treatment to Improve SPECT-CT Sensitivity Phase 4
Withdrawn NCT01329666 - Primary Hyperparathyroidism (PHPT): Early Effect of Vitamin D Phase 2/Phase 3
Completed NCT00891813 - Effectiveness and Safety of IV Zemplar in Patients on Hemodialysis and With Secondary Hyperparathyroidism Using iPTH/100 as Initial Dose Phase 4
Completed NCT00674154 - Effect of Vitamin D Treatment in Primary Hyperparathyroidism Phase 2/Phase 3
Completed NCT04299425 - Evaluating Impact of NIRAF Detection for Identifying Parathyroid Glands During Parathyroidectomy N/A
Completed NCT00975221 - Efficacy and Safety Study of Cinacalcet for the Treatment of Hypercalcemia in Patients With Primary Hyperparathyroidism Unable to Undergo Parathyroidectomy Phase 3
Withdrawn NCT03516747 - Preoperational Fine Needle Aspiration of Pathological Parathyroid Gland N/A
Completed NCT00485706 - Arterial Stiffness and Decreased Bone Buffering Capacity in Hemodialysis Patients N/A
Recruiting NCT01647503 - Differentially Expressed Proteins in Sporadic Parathyroid Tumors N/A
Completed NCT01042626 - Oral Peptones Load in Normocalcemic and Hypercalcemic Primary Hyperparathyroidism and Healthy Subjects N/A
Not yet recruiting NCT01021280 - Parathyroid Hormone (PTH) Homeostasis in Bartter Syndrome N/A
Not yet recruiting NCT01226810 - The Novel Approach of Minimally Invasive Parathyroid Surgery Requires Precise Identification and Localization of the Lesion Prior to Exploration N/A
Terminated NCT00415584 - Cinacalcet to Treat Hypercalcemia in Renal Transplant Recipients Phase 1/Phase 2
Completed NCT00581828 - Does Treatment of Hypovitaminosis D Increase Calcium Absorption? Phase 4
Completed NCT00126386 - Zometa for the Management of Tumor-induced Hypercalcemia and Malignant Bone Pain in the Community N/A